Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
9.65
+0.38 (4.10%)
At close: Sep 18, 2026, 4:00 PM EDT
9.64
-0.01 (-0.10%)
After-hours: Sep 18, 2026, 7:59 PM EDT
Absci Revenue
Absci had revenue of $318.00K in the quarter ending June 30, 2026, a decrease of -46.37%. This brings the company's revenue in the last twelve months to $1.56M, down -62.28% year-over-year. In the year 2025, Absci had annual revenue of $2.80M, down -38.24%.
Revenue (ttm)
$1.56M
Revenue Growth
-62.28%
P/S Ratio
1,060.91
Revenue / Employee
$11,150
Employees
140
Market Cap
1.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.80M | -1.73M | -38.24% |
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | 2.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Innoviva | 440.00M |
| Immunocore Holdings | 430.78M |
| Novavax | 413.80M |
| Syndax Pharmaceuticals | 252.25M |
| AnaptysBio | 232.39M |
| Taysha Gene Therapies | 5.49M |
| Inhibrx Biosciences | 1.30M |
ABSI News
- 3 days ago - Absci Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 days ago - Absci Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 10 days ago - Absci initiated with an Outperform at LifeSci Capital - TheFly
- 11 days ago - Absci price target raised to $15 from $13 at BTIG - TheFly
- 18 days ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Absci reports Q2 EPS (21c), consensus (20c) - TheFly
- 5 weeks ago - Absci Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Absci Earnings release: Q2 2026 - Filings